CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
GORE TAG® Thoracic Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00908388
NCT00908388N/ACompleted
CompareCT.gov

Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection

W.L.Gore & Associates·interventional·Posted May 25, 2009·Updated Oct 27, 2017

In Brief

A clinical study evaluating GORE TAG® Thoracic Endoprosthesis for Type B Aortic Dissection. Completed, enrolled 50 participants across 37 sites.

Detailed Summary

The primary objective of this study is to determine the safety and efficacy of the GORE Conformable TAG Thoracic Endoprosthesis (CTAG) for treatment of subjects with acute complicated type B aortic dissection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType B Aortic Dissection
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 25, 2009
Enrollment StartOct 1, 2009
Primary CompletionFeb 1, 2012
Study CompletionFeb 28, 2017
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.1 years ago

Interventions

GORE TAG® Thoracic Endoprosthesisdevice

Endoprosthetic Implant